...
首页> 外文期刊>Analytical chemistry >A Rapid, Reproducible, On-the-Fly Orthogonal Array Optimization Method for Targeted Protein Quantification by LC/MS and Its Application for Accurate and Sensitive Quantification of Carbonyl Reductases in Human Liver
【24h】

A Rapid, Reproducible, On-the-Fly Orthogonal Array Optimization Method for Targeted Protein Quantification by LC/MS and Its Application for Accurate and Sensitive Quantification of Carbonyl Reductases in Human Liver

机译:快速,可重复,实时正交阵列优化方法用于LC / MS定量分析目标蛋白及其在人肝中羰基还原酶的准确,灵敏定量中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Liquid chromatography (LC)/mass spectrometry (MS) in selected-reactions-monitoring (SRM) mode provides a powerful tool for targeted protein quantification. However, efficient, high-throughput strategies for proper selection of signature peptides (SP) for protein quantification and accurate optimization of their SRM conditions remain elusive. Here we describe an on-the-fly, orthogonal array optimization (OAO) approach that enables rapid, comprehensive, and reproducible SRM optimization of a large number of candidate peptides in a single nanoflow-LC/MS run. With the optimized conditions, many peptide candidates can be evaluated in biological matrixes for selection of the final SP. The OAO strategy employs a systematic experimental design that strategically varies product ions, declustering energy, and collision energy in a cycle of 25 consecutive SRM trials, which accurately reveals the effects of these factors on the signal-to-noise ratio of a candidate peptide and optimizes each. As proof of concept, we developed a highly sensitive, accurate, and reproducible method for the quantification of carbonyl reductases CBR1 and CBR3 in human liver. Candidate peptides were identified by nano-LC/LTQ/Orbitrap, filtered using a stringent set of criteria, and subjected to OAO. After evaluating both sensitivity and stability of the candidates, two SP were selected for quantification of each protein. As a result of the accurate OAO of assay conditions, sensitivities of 80 and 110 amol were achieved for CBR1 and CBR3, respectively. The method was validated and used to quantify the CBRs in 33 human liver samples. The mean level of CBR1 was 93.4 +- 49.7 (range: 26.2-241) ppm of total protein, and of CBR3 was 7.69 +- 4.38 (range: 1.26-17.9) ppm. Key observations of this study: (i) evaluation of peptide stability in the target matrix is essential for final selection of the SP; (ii) utilization of two unique SP contributes to high reliability of target protein quantification; (iii) it is beneficial to construct calibration curves using standard proteins of verified concentrations to avoid severe biases that may result if synthesized peptides alone are used. Overall, the OAO method is versatile and adaptable to high-throughput quantification of validated biomarkers identified by proteomic discovery experiments.
机译:选择性反应监控(SRM)模式下的液相色谱(LC)/质谱(MS)为目标蛋白质定量提供了强大的工具。然而,有效,高通量的策略难以正确选择签名肽(SP)进行蛋白质定量和准确优化其SRM条件。在这里,我们描述了一种动态的正交阵列优化(OAO)方法,该方法可在一次纳流LC / MS运行中对大量候选肽进行快速,全面且可重现的SRM优化。通过优化的条件,可以在生物基质中评估许多候选肽,以选择最终的SP。 OAO策略采用了系统的实验设计,可以在25个连续的SRM试验周期中策略性地改变产物离子,解簇能和碰撞能,从而准确地揭示了这些因素对候选肽的信噪比的影响。优化每个。作为概念验证,我们开发了一种高度灵敏,准确且可重现的方法,用于定量测定人肝中的羰基还原酶CBR1和CBR3。通过nano-LC / LTQ / Orbitrap鉴定候选肽,使用严格的标准进行过滤,然后进行OAO。在评估候选物的敏感性和稳定性之后,选择两个SP来定量每种蛋白质。由于测定条件的精确OAO,CBR1和CBR3的灵敏度分别达到80和110 amol。该方法经过验证,可用于定量分析33个人类肝样品中的CBR。 CBR1的平均水平为总蛋白的93.4±49.7(范围:26.2-241)ppm,CBR3的平均水平为7.69±4.38(范围:1.26-17.9)ppm。该研究的主要观察结果:(i)评估目标基质中肽的稳定性对于SP的最终选择至关重要; (ii)利用两个独特的SP可以提高目标蛋白质定量的可靠性; (iii)使用已验证浓度的标准蛋白质构建校准曲线是有益的,以避免单独使用合成肽可能导致的严重偏差。总体而言,OAO方法用途广泛,适用于通过蛋白质组学发现实验鉴定的已验证生物标志物的高通量定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号